Luis Jimenez

Time passing

TGA expedites COVID-19 approvals, while keeping up business as usual for other devices

The TGA continues to provide timely responses and support for new applications and emergency use applications. Our firm continues to be in active communication with the agency, which at the...
Picture 1

EC Acts Quickly – and issues proposal to delay MDR deadline amidst COVID Pandemic

With sweeping speed, the European Commission (EC) has issued its proposal to postpone the deadline of the transition from MDD to MDR. The goal is to have the European Parliament...
People review graph

2019 US 510(k) Clearances Analysis and FDA’s target to receive innovative technologies first in 2020

We have recently been covering several new initiatives at the United States FDA CDRH, and as such thought it would be fitting to provide a round-up for the 510(k) activities...
Process copy 2

A single review program for medical devices?

During this year’s Bio-Utah Summit in November 2019, Dr. Jeffrey Shuren, Director of the FDA’s Center for Devices and Radiological Health (CDRH) spoke about the new initiatives and modernization of...
Train-derailing

And so starts the MDR/Brexit fallout… First LRQA and now QS Zurich fall by the wayside

Breaking News: As of June 13th, Lloyds Register Quality Assurance (LRQA) withdrew from MDD and IVDD services (see the announcement here). It's official, the first notified body based in UK...
photo-1521931961826-fe48677230a5

TGA will no longer send “friendly reminders” for Annual Reports.

In a communication on May 15th, TGA announced they will no longer be providing courtesy formal correspondence requesting annual reports from Australian Sponsors, and failing to provide annual reports may...
shutterstock_552100717

Japan renews its participation in MDSAP until 2020

Japan’s participation in MDSAP (Medical Device Standardized Audit Program) has been a contributing factor in the exponential update of MDSAP by multinational companies. Japan’s MHLW and PMDA has been opting...
Distribution copy

The commercialization continuum: beyond product registrations

Your product is approved, now what? This is a question that can bring a painful realization to medical technology manufacturers and suppliers eagerly entering a new market. The appropriate preparation...
MDSAP article image

MDSAP Stakeholder Update (FDA, TGA, Health Canada, PMDA, ANVISA)

On Dec 5th, 2018 the representatives from US FDA, Brazil’s Anvisa, Japan’s PMDA, Australia’s TGA, and Health Canada met in Washington, DC with stakeholders from the medical device industry to...
TrainXstation

Halfway there? Will the MDR/IVDR train arrive on time – and what about Brexit?

As the implementation journey for the EU MDR/IVDR passes the halfway point, we provide an update to the current state of play and the impact on our industry. Many, if...

Search

Recent Posts

Categories

Categories

Archives

Archives

Archives